Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	GTPase activator activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D LARS1 TBC1D3C TBC1D3B RIN2 TBC1D3I TBC1D3G TBC1D3K TBC1D3F	1.83e-08	279	123	13	GO:0005096
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D LARS1 TBC1D3C TBC1D3B RIN2 EIF2B3 TBC1D3I TBC1D3G TBC1D3K RASGRP2 TBC1D3F	5.42e-07	507	123	15	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D LARS1 TBC1D3C TBC1D3B RIN2 EIF2B3 TBC1D3I TBC1D3G TBC1D3K RASGRP2 TBC1D3F	5.42e-07	507	123	15	GO:0030695
GeneOntologyMolecularFunction	peptide lactyltransferase (CoA-dependent) activity	CREBBP EP300	3.76e-05	2	123	2	GO:0120300
GeneOntologyMolecularFunction	histone H3K27 acetyltransferase activity	CREBBP EP300	3.76e-05	2	123	2	GO:0044017
GeneOntologyMolecularFunction	UDP-glycosyltransferase activity	MGAT4A EXT2 RXYLT1 B3GNT8 MGAT1 POGLUT1 GYS1	4.57e-05	153	123	7	GO:0008194
GeneOntologyMolecularFunction	hexosyltransferase activity	MGAT4A EXT2 GBA2 PIGZ B3GNT8 MGAT1 POGLUT1 GYS1	4.96e-05	211	123	8	GO:0016758
GeneOntologyMolecularFunction	enzyme activator activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D LARS1 TBC1D3C TBC1D3B FZR1 RIN2 TBC1D3I TBC1D3G TBC1D3K TBC1D3F	5.29e-05	656	123	14	GO:0008047
GeneOntologyMolecularFunction	glycosyltransferase activity	MGAT4A EXT2 RXYLT1 GBA2 PIGZ B3GNT8 MGAT1 POGLUT1 GYS1	7.47e-05	288	123	9	GO:0016757
GeneOntologyMolecularFunction	histone H3K18 acetyltransferase activity	CREBBP EP300	1.12e-04	3	123	2	GO:0043993
GeneOntologyMolecularFunction	acetylglucosaminyltransferase activity	MGAT4A EXT2 B3GNT8 MGAT1	1.99e-04	47	123	4	GO:0008375
GeneOntologyMolecularFunction	beta-adrenergic receptor kinase activity	GRK2 GRK3	2.24e-04	4	123	2	GO:0047696
GeneOntologyMolecularFunction	histone acetyltransferase activity	CREBBP TAF1 TAF1L EP300	2.74e-04	51	123	4	GO:0004402
GeneOntologyMolecularFunction	glucosyltransferase activity	GBA2 POGLUT1 GYS1	3.22e-04	22	123	3	GO:0046527
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	CREBBP TAF1 TAF1L EP300	3.67e-04	55	123	4	GO:0061733
GeneOntologyMolecularFunction	H3K27me3 modified histone binding	TAF1 TAF1L	3.72e-04	5	123	2	GO:0061628
GeneOntologyMolecularFunction	N-acyltransferase activity	PLA2G4E CREBBP TAF1 TAF1L EP300	4.23e-04	102	123	5	GO:0016410
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	CREBBP TAF1 TAF1L EP300	5.12e-04	60	123	4	GO:0034212
GeneOntologyMolecularFunction	histone modifying activity	BAZ1B CREBBP BAP1 KMT2D TAF1 TAF1L EP300	5.48e-04	229	123	7	GO:0140993
GeneOntologyMolecularFunction	RNA polymerase II general transcription initiation factor binding	CREBBP TAF1 TAF1L	5.99e-04	27	123	3	GO:0001091
GeneOntologyMolecularFunction	G protein-coupled receptor kinase activity	GRK2 GRK3	7.75e-04	7	123	2	GO:0004703
GeneOntologyMolecularFunction	acetylation-dependent protein binding	TAF1 TAF1L EP300	9.04e-04	31	123	3	GO:0140033
GeneOntologyMolecularFunction	p53 binding	CREBBP TAF1 TAF1L EP300	1.31e-03	77	123	4	GO:0002039
GeneOntologyMolecularFunction	RNA polymerase I general transcription initiation factor activity	TAF1 TAF1L	1.32e-03	9	123	2	GO:0001181
GeneOntologyMolecularFunction	N-acetyltransferase activity	CREBBP TAF1 TAF1L EP300	1.38e-03	78	123	4	GO:0008080
GeneOntologyMolecularFunction	promoter-specific chromatin binding	IRF3 TAF1 TAF1L EP300	1.73e-03	83	123	4	GO:1990841
GeneOntologyMolecularFunction	UDP-xylosyltransferase activity	RXYLT1 POGLUT1	2.00e-03	11	123	2	GO:0035252
GeneOntologyMolecularFunction	xylosyltransferase activity	RXYLT1 POGLUT1	2.00e-03	11	123	2	GO:0042285
GeneOntologyBiologicalProcess	activation of GTPase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	7.16e-11	109	127	11	GO:0090630
GeneOntologyBiologicalProcess	positive regulation of GTPase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D LARS1 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K RASGRP2 TBC1D3F	3.72e-09	244	127	13	GO:0043547
GeneOntologyBiologicalProcess	regulation of GTPase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D LARS1 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K RASGRP2 TBC1D3F	1.57e-07	335	127	13	GO:0043087
GeneOntologyBiologicalProcess	positive regulation of hydrolase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D LARS1 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K RASGRP2 TBC1D3F	1.29e-05	499	127	13	GO:0051345
GeneOntologyBiologicalProcess	glycosylation	FKRP MGAT4A EXT2 RXYLT1 GBA2 B3GNT8 MGAT1 POGLUT1 CHST4	4.56e-05	270	127	9	GO:0070085
GeneOntologyBiologicalProcess	positive regulation of molecular function	KCTD7 TBC1D3E TCAF1 TBC1D3 ANGPT1 TBC1D3H TBC1D3L TBC1D3D LARS1 TBC1D3C CREBBP TBC1D3B GHR FZR1 TRAF4 TAF1 TBC1D3I TBC1D3G EP300 TBC1D3K RASGRP2 TBC1D3F	5.83e-05	1430	127	22	GO:0044093
GeneOntologyBiologicalProcess	cellular response to L-leucine	UBR1 LARS1 EP300	6.23e-05	13	127	3	GO:0071233
GeneOntologyBiologicalProcess	glycoprotein metabolic process	FKRP MGAT4A EXT2 RXYLT1 HPSE B3GNT8 MGAT1 POGLUT1 CHST4 DSEL EP300	7.25e-05	430	127	11	GO:0009100
GeneOntologyBiologicalProcess	glycoprotein biosynthetic process	FKRP MGAT4A EXT2 RXYLT1 B3GNT8 MGAT1 POGLUT1 CHST4 DSEL EP300	7.41e-05	357	127	10	GO:0009101
GeneOntologyBiologicalProcess	regulation of autophagosome size	DNAJC16 CLN3	1.12e-04	3	127	2	GO:0016243
GeneOntologyBiologicalProcess	response to L-leucine	UBR1 LARS1 EP300	1.20e-04	16	127	3	GO:0043201
GeneOntologyBiologicalProcess	heparin metabolic process	ANGPT1 EXT2 HPSE	1.46e-04	17	127	3	GO:0030202
GeneOntologyBiologicalProcess	macromolecule glycosylation	FKRP MGAT4A EXT2 RXYLT1 B3GNT8 MGAT1 POGLUT1 CHST4	1.70e-04	252	127	8	GO:0043413
GeneOntologyBiologicalProcess	protein glycosylation	FKRP MGAT4A EXT2 RXYLT1 B3GNT8 MGAT1 POGLUT1 CHST4	1.70e-04	252	127	8	GO:0006486
GeneOntologyBiologicalProcess	positive regulation of catalytic activity	TBC1D3E TBC1D3 ANGPT1 TBC1D3H TBC1D3L TBC1D3D LARS1 TBC1D3C TBC1D3B GHR FZR1 TRAF4 TBC1D3I TBC1D3G TBC1D3K RASGRP2 TBC1D3F	1.91e-04	1028	127	17	GO:0043085
GeneOntologyBiologicalProcess	N-terminal peptidyl-lysine acetylation	CREBBP EP300	2.24e-04	4	127	2	GO:0018076
HumanPheno	Pilomatrixoma	CREBBP KMT2D EP300	5.22e-05	9	45	3	HP:0030434
HumanPheno	Abnormal nasal dorsum morphology	SLC25A24 UBR1 RPGRIP1L NUP85 ITGA8 LBR CREBBP GHR KMT2D EP300	7.03e-05	262	45	10	HP:0011119
HumanPheno	Plantar crease between first and second toes	CREBBP EP300	7.63e-05	2	45	2	HP:0008107
HumanPheno	Aortic isthmus hypoplasia	CREBBP EP300	7.63e-05	2	45	2	HP:0034227
HumanPheno	High axial triradius	CREBBP EP300	7.63e-05	2	45	2	HP:0001042
HumanPheno	Involuntary movements	KCTD7 CACNA1B CACNA1S PDCD1 RPGRIP1L OXR1 FKRP MARS1 BAZ1B EXT2 GBA2 CREBBP CHRNA2 BAP1 FZR1 CLPB MYH14 CLN3 ZFYVE26 TAF1 SELENOI RMND1 EP300	9.89e-05	1248	45	23	HP:0004305
HumanPheno	Abnormal nasolacrimal system morphology	SLC25A24 UBR1 CREBBP KMT2D TAF1 EP300	9.96e-05	87	45	6	HP:0000614
HumanPheno	Parietal foramina	EXT2 CREBBP EP300	2.19e-04	14	45	3	HP:0002697
HumanPheno	Laryngeal cartilage malformation	CREBBP EP300	2.28e-04	3	45	2	HP:0008752
HumanPheno	Phobia	CREBBP EP300	2.28e-04	3	45	2	HP:5200232
HumanPheno	Agoraphobia	CREBBP EP300	2.28e-04	3	45	2	HP:0000756
HumanPheno	Humoral immunodeficiency	CREBBP EP300	2.28e-04	3	45	2	HP:0005363
HumanPheno	Prominent nasal septum	CREBBP EP300	2.28e-04	3	45	2	HP:0005322
HumanPheno	Radial deviation of thumb terminal phalanx	CREBBP EP300	2.28e-04	3	45	2	HP:0005895
Domain	TBC	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B USP6 TBC1D3I TBC1D3G TBC1D3K TBC1D3F	1.51e-14	49	123	11	SM00164
Domain	RabGAP-TBC	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B USP6 TBC1D3I TBC1D3G TBC1D3K TBC1D3F	3.87e-14	53	123	11	PF00566
Domain	Rab-GTPase-TBC_dom	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B USP6 TBC1D3I TBC1D3G TBC1D3K TBC1D3F	6.00e-14	55	123	11	IPR000195
Domain	TBC_RABGAP	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B USP6 TBC1D3I TBC1D3G TBC1D3K TBC1D3F	6.00e-14	55	123	11	PS50086
Domain	BROMODOMAIN_1	BAZ1B CREBBP TRIM66 TAF1 TAF1L EP300	1.42e-07	37	123	6	PS00633
Domain	Bromodomain	BAZ1B CREBBP TRIM66 TAF1 TAF1L EP300	1.68e-07	38	123	6	PF00439
Domain	BROMODOMAIN_2	BAZ1B CREBBP TRIM66 TAF1 TAF1L EP300	2.69e-07	41	123	6	PS50014
Domain	Bromodomain	BAZ1B CREBBP TRIM66 TAF1 TAF1L EP300	3.12e-07	42	123	6	IPR001487
Domain	BROMO	BAZ1B CREBBP TRIM66 TAF1 TAF1L EP300	3.12e-07	42	123	6	SM00297
Domain	-	BAZ1B CREBBP TRIM66 TAF1 TAF1L EP300	3.12e-07	42	123	6	1.20.920.10
Domain	Bromodomain_CS	BAZ1B CREBBP TAF1 TAF1L EP300	6.72e-07	26	123	5	IPR018359
Domain	Nuc_rcpt_coact_CREBbp	CREBBP EP300	4.30e-05	2	123	2	IPR014744
Domain	TFIID_sub1_DUF3591	TAF1 TAF1L	4.30e-05	2	123	2	IPR022591
Domain	ZnF_TAZ	CREBBP EP300	4.30e-05	2	123	2	SM00551
Domain	CAPS	CADPS CADPS2	4.30e-05	2	123	2	IPR033227
Domain	-	CREBBP EP300	4.30e-05	2	123	2	1.20.1020.10
Domain	RING_CBP-p300	CREBBP EP300	4.30e-05	2	123	2	IPR010303
Domain	-	CREBBP EP300	4.30e-05	2	123	2	1.10.1630.10
Domain	Creb_binding	CREBBP EP300	4.30e-05	2	123	2	PF09030
Domain	TBP-binding	TAF1 TAF1L	4.30e-05	2	123	2	PF09247
Domain	zf-TAZ	CREBBP EP300	4.30e-05	2	123	2	PF02135
Domain	ZF_TAZ	CREBBP EP300	4.30e-05	2	123	2	PS50134
Domain	DUF3591	TAF1 TAF1L	4.30e-05	2	123	2	PF12157
Domain	M60-like	TCAF2 TCAF1	4.30e-05	2	123	2	SM01276
Domain	KAT11	CREBBP EP300	4.30e-05	2	123	2	SM01250
Domain	Znf_TAZ	CREBBP EP300	4.30e-05	2	123	2	IPR000197
Domain	KIX	CREBBP EP300	4.30e-05	2	123	2	PF02172
Domain	TAF_II_230-bd	TAF1 TAF1L	4.30e-05	2	123	2	IPR009067
Domain	HAT_KAT11	CREBBP EP300	4.30e-05	2	123	2	PF08214
Domain	KIX	CREBBP EP300	4.30e-05	2	123	2	PS50952
Domain	CBP_P300_HAT	CREBBP EP300	4.30e-05	2	123	2	IPR031162
Domain	Peptidase_M60_dom	TCAF2 TCAF1	4.30e-05	2	123	2	IPR031161
Domain	-	TAF1 TAF1L	4.30e-05	2	123	2	1.10.1100.10
Domain	DUF902	CREBBP EP300	4.30e-05	2	123	2	PF06001
Domain	Peptidase_M60	TCAF2 TCAF1	4.30e-05	2	123	2	PF13402
Domain	-	CREBBP EP300	4.30e-05	2	123	2	1.10.246.20
Domain	Histone_AcTrfase_Rtt109/CBP	CREBBP EP300	4.30e-05	2	123	2	IPR013178
Domain	KIX_dom	CREBBP EP300	4.30e-05	2	123	2	IPR003101
Domain	TAF1_animal	TAF1 TAF1L	4.30e-05	2	123	2	IPR011177
Domain	CBP_P300_HAT	CREBBP EP300	4.30e-05	2	123	2	PS51727
Domain	PEPTIDASE_M60	TCAF2 TCAF1	4.30e-05	2	123	2	PS51723
Domain	Exostosin	EXT2 RXYLT1	4.25e-04	5	123	2	PF03016
Domain	Exostosin	EXT2 RXYLT1	4.25e-04	5	123	2	IPR004263
Domain	DUF1041	CADPS CADPS2	4.25e-04	5	123	2	SM01145
Domain	Nuc_rcpt_coact	CREBBP EP300	6.34e-04	6	123	2	IPR009110
Domain	Munc13_1	CADPS CADPS2	8.84e-04	7	123	2	IPR014770
Domain	MHD1	CADPS CADPS2	8.84e-04	7	123	2	PS51258
Domain	Ca_chan_IQ	CACNA1B CACNA1S	8.84e-04	7	123	2	SM01062
Domain	Ca_chan_IQ	CACNA1B CACNA1S	8.84e-04	7	123	2	PF08763
Domain	DUF1041	CADPS CADPS2	8.84e-04	7	123	2	PF06292
Domain	VDCC_a1su_IQ	CACNA1B CACNA1S	8.84e-04	7	123	2	IPR014873
Domain	GPCR_kinase	GRK2 GRK3	8.84e-04	7	123	2	IPR000239
Domain	GPHH	CACNA1B CACNA1S	8.84e-04	7	123	2	PF16905
Domain	CAPS_dom	CADPS CADPS2	8.84e-04	7	123	2	IPR010439
Domain	GPHH_dom	CACNA1B CACNA1S	8.84e-04	7	123	2	IPR031649
Domain	C2	RPGRIP1L WWP2 PLA2G4E CADPS CADPS2	1.75e-03	131	123	5	PF00168
Domain	VDCCAlpha1	CACNA1B CACNA1S	1.87e-03	10	123	2	IPR002077
Domain	C2	RPGRIP1L WWP2 PLA2G4E CADPS CADPS2	2.14e-03	137	123	5	SM00239
Domain	-	MARS1 LARS1	2.28e-03	11	123	2	1.10.730.10
Domain	C2	RPGRIP1L WWP2 PLA2G4E CADPS CADPS2	2.50e-03	142	123	5	PS50004
Domain	Class_I_gatase-like	TCAF2 TCAF1	2.72e-03	12	123	2	IPR029062
Domain	OLF	OLFML2B OLFML2A	3.20e-03	13	123	2	PF02191
Domain	OLF	OLFML2B OLFML2A	3.20e-03	13	123	2	PS51132
Domain	Olfac-like_dom	OLFML2B OLFML2A	3.20e-03	13	123	2	IPR003112
Domain	OLF	OLFML2B OLFML2A	3.20e-03	13	123	2	SM00284
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH14	3.72e-03	14	123	2	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH14	3.72e-03	14	123	2	IPR024743
Domain	MT	DNAH3 DNAH14	3.72e-03	14	123	2	PF12777
Domain	AAA_8	DNAH3 DNAH14	3.72e-03	14	123	2	PF12780
Domain	DHC_fam	DNAH3 DNAH14	4.27e-03	15	123	2	IPR026983
Domain	Dynein_heavy	DNAH3 DNAH14	4.27e-03	15	123	2	PF03028
Domain	Dynein_heavy_dom	DNAH3 DNAH14	4.27e-03	15	123	2	IPR004273
Domain	tRNAsynth_Ia_anticodon-bd	MARS1 LARS1	4.27e-03	15	123	2	IPR009080
Domain	fn3	IL20RB GHR PTPRB CNTN3 CNTN1	4.39e-03	162	123	5	PF00041
Domain	C2_dom	RPGRIP1L WWP2 PLA2G4E CADPS CADPS2	4.62e-03	164	123	5	IPR000008
Domain	aa-tRNA-synth_I_CS	MARS1 LARS1	6.14e-03	18	123	2	IPR001412
Domain	ZF_ZZ_2	CREBBP EP300	6.14e-03	18	123	2	PS50135
Domain	ZF_ZZ_1	CREBBP EP300	6.14e-03	18	123	2	PS01357
Domain	ZZ	CREBBP EP300	6.14e-03	18	123	2	PF00569
Domain	Channel_four-helix_dom	CACNA1B CACNA1S SLC9C2	6.30e-03	57	123	3	IPR027359
Domain	-	CACNA1B CACNA1S SLC9C2	6.30e-03	57	123	3	1.20.120.350
Pathway	WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B SLFN13 TBC1D3I TBC1D3G TBC1D3K	7.37e-10	99	91	10	M46448
Pathway	REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION	IRF3 CREBBP EP300	2.58e-06	5	91	3	M27228
Pathway	KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY	IRF3 CREBBP EP300	2.13e-05	9	91	3	M47451
Pathway	REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY	IRF3 CREBBP EP300	1.12e-04	15	91	3	M953
Pathway	REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA	TUT7 CREBBP EP300	1.66e-04	17	91	3	M48025
Pubmed	TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12.	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	9.88e-28	11	127	11	16863688
Pubmed	Identification of novel sequences in the repertoire of hypervariable TRE17 genes from immortalized nonmalignant and malignant human keratinocytes.	TBC1D3 TBC1D3D USP6 TBC1D3F	1.70e-10	4	127	4	8406013
Pubmed	The Tre2 (USP6) oncogene is a hominoid-specific gene.	TBC1D3 TBC1D3D TBC1D3C USP6	8.45e-10	5	127	4	12604796
Pubmed	Human TRE17 oncogene is generated from a family of homologous polymorphic sequences by single-base changes.	TBC1D3 TBC1D3D USP6 TBC1D3F	8.45e-10	5	127	4	8471161
Pubmed	DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.	TBC1D3E TBC1D3 TBC1D3H TBC1D3D TBC1D3B TBC1D3G TBC1D3F	1.08e-08	74	127	7	16625196
Pubmed	Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1.	IRF3 CREBBP EP300	4.76e-08	3	127	3	9488451
Pubmed	Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions.	IRF3 CREBBP EP300	4.76e-08	3	127	3	12473110
Pubmed	Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7.	IRF3 CREBBP EP300	4.76e-08	3	127	3	14668346
Pubmed	Characterization of monoclonal antibodies raised against p300: both p300 and CBP are present in intracellular TBP complexes.	CREBBP TAF1 EP300	1.90e-07	4	127	3	8995708
Pubmed	HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators.	IRF3 CREBBP EP300	1.90e-07	4	127	3	11314014
Pubmed	Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo.	IRF3 CREBBP EP300	1.90e-07	4	127	3	9660935
Pubmed	Interferon regulatory factor-7 synergizes with other transcription factors through multiple interactions with p300/CBP coactivators.	IRF3 CREBBP EP300	1.90e-07	4	127	3	12604599
Pubmed	MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis.	CREBBP KMT2D EP300	1.90e-07	4	127	3	28398509
Pubmed	Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex.	IRF3 CREBBP EP300	1.90e-07	4	127	3	11940575
Pubmed	PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer.	TBC1D3 TBC1D3D TBC1D3F	1.90e-07	4	127	3	12359748
Pubmed	Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction.	IRF3 CREBBP EP300	1.90e-07	4	127	3	17126870
Pubmed	New nomenclature for chromatin-modifying enzymes.	CREBBP KMT2D TAF1 TAF1L EP300	2.16e-06	57	127	5	18022353
Pubmed	Immune evasion strategy involving propionylation by the KSHV interferon regulatory factor 1 (vIRF1).	IRF3 CREBBP EP300	5.60e-06	10	127	3	37023208
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	IGSF8 FKRP DNAJC16 TUT7 EXT2 RXYLT1 LBR PIGU PDIA4 OLFML2A FAT1 POGLUT1 SGPL1 SELENOI DSEL USP48	8.29e-06	1201	127	16	35696571
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	BAZ1B CREBBP TRIM66 TAF1 EP300	8.44e-06	75	127	5	25593309
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	IGSF8 TCAF1 TBRG4 NUP85 FKRP MARS1 DNAJC16 TUT7 LARS1 EXT2 LBR PDIA4 MGAT1 EIF2B3	9.47e-06	942	127	14	31073040
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	RPGRIP1L TTLL3 NUP85 OXR1 LARS1 BAZ1B FRYL GBA2 ATP8B2 BAP1 PDIA4 STK32A TRIM66 MYH14 GLO1 LEPROT	1.26e-05	1242	127	16	30973865
Pubmed	Loss of p300 accelerates MDS-associated leukemogenesis.	CREBBP EP300	1.32e-05	2	127	2	27881875
Pubmed	CAPS1 and CAPS2 regulate stability and recruitment of insulin granules in mouse pancreatic beta cells.	CADPS CADPS2	1.32e-05	2	127	2	18177725
Pubmed	Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.	CREBBP EP300	1.32e-05	2	127	2	34845315
Pubmed	p300 plays a critical role in maintaining cardiac mitochondrial function and cell survival in postnatal hearts.	CREBBP EP300	1.32e-05	2	127	2	19729597
Pubmed	Crystal structure of IRF-3 in complex with CBP.	IRF3 CREBBP	1.32e-05	2	127	2	16154084
Pubmed	CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer.	CREBBP EP300	1.32e-05	2	127	2	39287984
Pubmed	Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association.	IRF3 CREBBP	1.32e-05	2	127	2	18272581
Pubmed	Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH.	CREBBP EP300	1.32e-05	2	127	2	20717166
Pubmed	The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.	CREBBP EP300	1.32e-05	2	127	2	25893291
Pubmed	Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.	CREBBP EP300	1.32e-05	2	127	2	11559821
Pubmed	CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas.	CREBBP EP300	1.32e-05	2	127	2	32576962
Pubmed	Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.	CREBBP EP300	1.32e-05	2	127	2	19822209
Pubmed	A specific CBP/p300-dependent gene expression programme drives the metabolic remodelling in late stages of spermatogenesis.	CREBBP EP300	1.32e-05	2	127	2	24522976
Pubmed	CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement.	CREBBP EP300	1.32e-05	2	127	2	21847097
Pubmed	The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin.	PTPRB CNTN1	1.32e-05	2	127	2	7628014
Pubmed	Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders.	TAF1 TAF1L	1.32e-05	2	127	2	38804708
Pubmed	p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes.	CREBBP EP300	1.32e-05	2	127	2	34813504
Pubmed	CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins.	CADPS CADPS2	1.32e-05	2	127	2	18022372
Pubmed	Rubinstein-Taybi Syndrome	CREBBP EP300	1.32e-05	2	127	2	20301699
Pubmed	Sustained expression of a neuron-specific isoform of the Taf1 gene in development stages and aging in mice.	TAF1 TAF1L	1.32e-05	2	127	2	22842574
Pubmed	Multi-ligand interactions with receptor-like protein tyrosine phosphatase beta: implications for intercellular signaling.	PTPRB CNTN1	1.32e-05	2	127	2	9584610
Pubmed	Potential biomarker of metformin action.	CREBBP EP300	1.32e-05	2	127	2	24639469
Pubmed	The histone acetyl transferases CBP and p300 regulate stress response pathways in synovial fibroblasts at transcriptional and functional levels.	CREBBP EP300	1.32e-05	2	127	2	37816914
Pubmed	Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3.	GRK2 GRK3	1.32e-05	2	127	2	10198406
Pubmed	Binding of p300/CBP co-activators by polyoma large T antigen.	CREBBP EP300	1.32e-05	2	127	2	11438528
Pubmed	Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.	CREBBP EP300	1.32e-05	2	127	2	10918613
Pubmed	Frameshift Mutations in the Mononucleotide Repeats of TAF1 and TAF1L Genes in Gastric and Colorectal Cancers with Regional Heterogeneity.	TAF1 TAF1L	1.32e-05	2	127	2	27571988
Pubmed	CAPS-1 requires its C2, PH, MHD1 and DCV domains for dense core vesicle exocytosis in mammalian CNS neurons.	CADPS CADPS2	1.32e-05	2	127	2	28883501
Pubmed	Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 Isoforms.	TAF1 TAF1L	1.32e-05	2	127	2	34403156
Pubmed	Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity.	CREBBP EP300	1.32e-05	2	127	2	35502657
Pubmed	p300 and cAMP response element-binding protein-binding protein in skeletal muscle homeostasis, contractile function, and survival.	CREBBP EP300	1.32e-05	2	127	2	31898871
Pubmed	G-protein coupled receptor kinase 2 and 3 expression in human detrusor cultured smooth muscle cells.	GRK2 GRK3	1.32e-05	2	127	2	11762794
Pubmed	Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity.	CREBBP EP300	1.32e-05	2	127	2	30888860
Pubmed	Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer.	CREBBP EP300	1.32e-05	2	127	2	27881443
Pubmed	Spatiotemporal expression of histone acetyltransferases, p300 and CBP, in developing embryonic hearts.	CREBBP EP300	1.32e-05	2	127	2	19272189
Pubmed	Suppression of type I interferon production by porcine epidemic diarrhea virus and degradation of CREB-binding protein by nsp1.	IRF3 CREBBP	1.32e-05	2	127	2	26773386
Pubmed	Differential contribution of p300 and CBP to regulatory element acetylation in mESCs.	CREBBP EP300	1.32e-05	2	127	2	32690000
Pubmed	CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice.	CREBBP EP300	1.32e-05	2	127	2	30953353
Pubmed	Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control.	CREBBP EP300	1.32e-05	2	127	2	21803292
Pubmed	HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.	CREBBP EP300	1.32e-05	2	127	2	9811832
Pubmed	Two independent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cells.	CREBBP EP300	1.32e-05	2	127	2	24089570
Pubmed	Activation of interferon regulatory factor 3 in response to DNA-damaging agents.	IRF3 CREBBP	1.32e-05	2	127	2	10521456
Pubmed	A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome.	CREBBP KMT2D	1.32e-05	2	127	2	27999180
Pubmed	Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease.	CREBBP EP300	1.32e-05	2	127	2	15706485
Pubmed	AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.	CREBBP EP300	1.32e-05	2	127	2	39266679
Pubmed	A boy with classical Rubinstein-Taybi syndrome but no detectable mutation in the CREBBP and EP300 genes.	CREBBP EP300	1.32e-05	2	127	2	22303793
Pubmed	Two distinct secretory vesicle-priming steps in adrenal chromaffin cells.	CADPS CADPS2	1.32e-05	2	127	2	20855507
Pubmed	Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function.	CREBBP EP300	1.32e-05	2	127	2	34732714
Pubmed	Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition.	CREBBP EP300	1.32e-05	2	127	2	34019788
Pubmed	Cloning of GRK2 cDNA from S49 murine lymphoma cells.	GRK2 GRK3	1.32e-05	2	127	2	8638670
Pubmed	Endogenous CCAAT/enhancer binding protein beta and p300 are both regulated by growth hormone to mediate transcriptional activation.	CREBBP EP300	1.32e-05	2	127	2	15860545
Pubmed	Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndrome.	CREBBP EP300	1.32e-05	2	127	2	29460469
Pubmed	CAPS facilitates filling of the rapidly releasable pool of large dense-core vesicles.	CADPS CADPS2	1.32e-05	2	127	2	18495893
Pubmed	Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer.	CREBBP EP300	1.32e-05	2	127	2	24551300
Pubmed	Dissecting the roles of GRK2 and GRK3 in μ-opioid receptor internalization and β-arrestin2 recruitment using CRISPR/Cas9-edited HEK293 cells.	GRK2 GRK3	1.32e-05	2	127	2	33060647
Pubmed	Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma.	CREBBP EP300	1.32e-05	2	127	2	33911074
Pubmed	The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300.	CREBBP EP300	1.32e-05	2	127	2	9018065
Pubmed	Coactivators p300 and CBP maintain the identity of mouse embryonic stem cells by mediating long-range chromatin structure.	CREBBP EP300	1.32e-05	2	127	2	24648406
Pubmed	CBP and P300 regulate distinct gene networks required for human primary myoblast differentiation and muscle integrity.	CREBBP EP300	1.32e-05	2	127	2	30135524
Pubmed	Distribution of co-activators CBP and p300 during mouse oocyte and embryo development.	CREBBP EP300	1.32e-05	2	127	2	16596650
Pubmed	G protein--coupled receptor kinases.	GRK2 GRK3	1.32e-05	2	127	2	8035170
Pubmed	The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation.	CREBBP EP300	1.32e-05	2	127	2	29217654
Pubmed	Evidence for opposing selective forces operating on human-specific duplicated TCAF genes in Neanderthals and humans.	TCAF2 TCAF1	1.32e-05	2	127	2	34433829
Pubmed	Differences in the interactions of oncogenic adenovirus 12 early region 1A and nononcogenic adenovirus 2 early region 1A with the cellular coactivators p300 and CBP.	CREBBP EP300	1.32e-05	2	127	2	10049825
Pubmed	Identification and characterization of photomedins: novel olfactomedin-domain-containing proteins with chondroitin sulphate-E-binding activity.	OLFML2B OLFML2A	1.32e-05	2	127	2	15836428
Pubmed	CBP/p300 acetyltransferase activity in hematologic malignancies.	CREBBP EP300	1.32e-05	2	127	2	27380996
Pubmed	CREBBP and p300 lysine acetyl transferases in the DNA damage response.	CREBBP EP300	1.32e-05	2	127	2	29170789
Pubmed	Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesis.	CREBBP EP300	1.32e-05	2	127	2	21555743
Pubmed	CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells.	CREBBP EP300	1.32e-05	2	127	2	12646247
Pubmed	Histone acetyltransferase activities of cAMP-regulated enhancer-binding protein and p300 in tissues of fetal, young, and old mice.	CREBBP EP300	1.32e-05	2	127	2	11867645
Pubmed	Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue.	CREBBP EP300	1.32e-05	2	127	2	11963968
Pubmed	Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300.	CREBBP EP300	1.32e-05	2	127	2	9528808
Pubmed	Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines.	CREBBP EP300	1.32e-05	2	127	2	12696060
Pubmed	Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus.	IRF3 CREBBP	1.32e-05	2	127	2	17761676
Pubmed	TAFII250, Egr-1, and D-type cyclin expression in mice and neonatal rat cardiomyocytes treated with doxorubicin.	TAF1 TAF1L	1.32e-05	2	127	2	10070062
Pubmed	CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain.	CREBBP EP300	1.32e-05	2	127	2	36109165
Pubmed	Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300.	CREBBP EP300	1.32e-05	2	127	2	12242694
Pubmed	CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms.	CREBBP EP300	1.32e-05	2	127	2	31182547
Interaction	OPA6 interactions	WWP2 FZR1 EP300	4.27e-06	6	122	3	int:OPA6
Interaction	PTPRB interactions	GHR PTPRB ADGRF5 CNTN1 FTSJ3	1.41e-05	51	122	5	int:PTPRB
Cytoband	Ensembl 112 genes in cytogenetic band chr17q12	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SLFN13 TBC1D3I TBC1D3G TBC1D3K TBC1D3F	1.36e-14	149	127	12	chr17q12
Cytoband	17q12	TBC1D3 TBC1D3H TBC1D3C TBC1D3B SLFN13 TBC1D3F	3.61e-07	99	127	6	17q12
Cytoband	7q35	TCAF2 TCAF1 PDIA4	4.88e-04	55	127	3	7q35
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP TAF1 EP300	4.84e-05	17	77	3	486
GeneFamily	Fibronectin type III domain containing	IL20RB GHR PTPRB CNTN3 CNTN1	6.03e-04	160	77	5	555
GeneFamily	Mannosyl-glycoprotein N-acetylglucosaminyltransferases	MGAT4A MGAT1	6.32e-04	9	77	2	435
GeneFamily	Dyneins, axonemal	DNAH3 DNAH14	2.34e-03	17	77	2	536
GeneFamily	Cadherin related	DCHS2 FAT1	2.34e-03	17	77	2	24
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP EP300	2.62e-03	18	77	2	91
GeneFamily	Aminoacyl tRNA synthetases, Class I	MARS1 LARS1	2.92e-03	19	77	2	131
GeneFamily	Glycosyl transferases group 1 domain containing\|Phosphatidylinositol glycan anchor biosynthesis	PIGU PIGZ	3.57e-03	21	77	2	680
GeneFamily	Calcium voltage-gated channel subunits	CACNA1B CACNA1S	5.45e-03	26	77	2	253
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F	2.79e-09	90	124	9	PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 ANGPT1 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F	5.04e-07	213	124	10	PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 ANGPT1 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F	5.04e-07	213	124	10	PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05	TBC1D3 ANGPT1 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F	1.61e-06	242	124	10	PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TTLL3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F	1.88e-05	320	124	10	PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F	4.12e-05	281	124	9	PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F	4.12e-05	281	124	9	PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	STK32B OOEP HPSE CHRNA2 STK32A OXTR	4.57e-07	101	127	6	cf52c93f523c5f25bd45519a1444ce7bd1d8b577
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	STK32B OOEP HPSE CHRNA2 STK32A OXTR RASGRP2	5.93e-07	170	127	7	8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / Treatment groups by lineage, cell group, cell type	NAPSA CYP4B1 OLFML2B PDIA4 MYH14 DSEL CADPS2	1.64e-06	198	127	7	655df75b9692d815c7f6910275e1f684ac63bf62
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	STK32B OOEP HPSE STK32A FAT1 RASGRP2	1.92e-06	129	127	6	6bc85761dea1f97c19bb379a99e4daf85d53201e
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	STK32B OOEP CHRNA2 STK32A OXTR RASGRP2	6.92e-06	161	127	6	dccb61d5e17a8f1c6d1fc146ee389f567659a0f0
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANGPT1 ITGA8 PKD2L1 GHR FAT1 RASGRP2	9.12e-06	169	127	6	bddb28a8b9afbe4a68f082e82caf96a6666fc674
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANGPT1 ITGA8 PKD2L1 GHR FAT1 RASGRP2	9.12e-06	169	127	6	5ce46bac8e767feec7ecdc61689de225c49bd3f7
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANGPT1 ITGA8 PKD2L1 GHR FAT1 RASGRP2	1.11e-05	175	127	6	bc6bd8c3ce956245ef4db91af9501649d5c09478
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANGPT1 ITGA8 HPSE CHRNA2 RIN2 DSEL	1.19e-05	177	127	6	85e270b4a0b0da77ffe5987a099e827c02a4adf3
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP4B1 ITGA8 HPSE PTPRB GYS1 ADGRF5	1.27e-05	179	127	6	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANGPT1 ITGA8 HPSE CHRNA2 RIN2 DSEL	1.48e-05	184	127	6	32473dbdb2de66391157c5814ef34e790806e4f2
ToppCell	droplet-Lung-3m-Endothelial-arterial_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYP4B1 STK32B STK32A PTPRB ADGRF5 CADPS2	1.57e-05	186	127	6	b80aaeebc03a318052076d2f02c123f5ddc5e73a
ToppCell	droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYP4B1 STK32B STK32A PTPRB ADGRF5 CADPS2	1.57e-05	186	127	6	8a8ed1502542d4895cba3fd5d534256206578716
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	UBR1 OXR1 CREBBP KLHL20 TAF1 EP300	1.57e-05	186	127	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANGPT1 ITGA8 HPSE CHRNA2 RIN2 DSEL	1.67e-05	188	127	6	6ee3f8f94ea7bdf652c9575fc65bff08070093a4
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANGPT1 ITGA8 GHR OLFML2A CNTN3 CNTN1	1.72e-05	189	127	6	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	OXR1 ITGA8 PTPRB RIN2 ADGRF5 CADPS2	1.72e-05	189	127	6	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	ITGA8 OLFML2A GRK3 SLFN13 CNTN3 CNTN1	1.77e-05	190	127	6	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	NAPSA CYP4B1 FAT1 MYH14 ADGRF5 CADPS2	1.83e-05	191	127	6	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANGPT1 ITGA8 HPSE CHRNA2 RIN2 DSEL	1.88e-05	192	127	6	6a252e298f8a454623fa9c1c893a7a45a886d694
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ANGPT1 ITGA8 GHR CNTN3 CADPS2 CNTN1	1.94e-05	193	127	6	9f69edc97b868d23998abc98928a2e89a885ef8a
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP4B1 GHR OLFML2A PTPRB RIN2 ADGRF5	1.99e-05	194	127	6	f159ef8541d75a4e98468947f231bb463bec922c
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ANGPT1 ITGA8 GHR CNTN3 CADPS2 CNTN1	1.99e-05	194	127	6	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	MGAT4A FRYL PTPRB RIN2 ADGRF5 CADPS2	2.05e-05	195	127	6	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NAPSA CYP4B1 DNAH14 MYH14 ADGRF5 CADPS2	2.05e-05	195	127	6	9406866f99555198a9be311fbd65751b70f35446
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	MGAT4A FRYL PTPRB RIN2 ADGRF5 CADPS2	2.05e-05	195	127	6	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NAPSA CYP4B1 MYH14 ALOXE3 DSEL CADPS2	2.17e-05	197	127	6	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ANGPT1 ITGA8 GHR CNTN3 CADPS2 CNTN1	2.17e-05	197	127	6	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NAPSA OLFML2B PDIA4 STK32A FAT1 CADPS2	2.24e-05	198	127	6	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	LPS_anti-TNF-Epithelial_alveolar\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NAPSA CYP4B1 PDIA4 MYH14 DSEL CADPS2	2.24e-05	198	127	6	53e9ed1b19cb26be58da0f37057caca0cdfaabeb
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NAPSA CYP4B1 PDIA4 MYH14 DSEL CADPS2	2.24e-05	198	127	6	82bcd44f8744e7e8477fbfd871a52f3d1a8b3adc
ToppCell	LPS_IL1RA-Epithelial_alveolar\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NAPSA CYP4B1 PDIA4 MYH14 DSEL CADPS2	2.30e-05	199	127	6	5b140ac88ebc25ce397ae577e48f3e271faf46e7
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NAPSA CYP4B1 PDIA4 MYH14 DSEL CADPS2	2.30e-05	199	127	6	121de4e02585de3a3010398387c523bacf8ce546
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR-L2-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANGPT1 ITGA8 HPSE CHRNA2 RIN2 DSEL	2.37e-05	200	127	6	04954fbe1e2264077228bb582c9a5897a70e6da2
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	NAPSA CYP4B1 CHRNA2 STK32A MYH14 GYS1	2.37e-05	200	127	6	eac33be484dc443794e66e473f03e98406c2983e
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANGPT1 ITGA8 HPSE CHRNA2 RIN2 DSEL	2.37e-05	200	127	6	bfdafb024a7b20d46837b2e6480dd4929253cd62
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	STK32B OOEP HPSE OXTR RASGRP2	4.43e-05	136	127	5	e3a2425ba5ef538dbacab1479e682837ae42a888
ToppCell	Mild/Remission-B_naive-1\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TCAF1 TUT7 EEF1G GRK2 GRK3	5.63e-05	143	127	5	bd3f5fbd4e9e4dc414682db5607494f3ce988deb
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	STK32B OOEP CHRNA2 OXTR RASGRP2	5.82e-05	144	127	5	71107275767a0728541a3695715c44874b3e5efc
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1B CHRNA2 MYH14 SLFN13 FTSJ3	8.76e-05	157	127	5	4766f7d545bf2d775390589460677519cb92f4d5
ToppCell	facs-Brain_Myeloid-Cerebellum-24m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PDCD1 ANGPT1 B3GNT8 RASGRP2	9.02e-05	158	127	5	f41ee21e5888359d817be1e3a902c132cb68e350
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma\|TCGA-Bladder / Sample_Type by Project: Shred V9	TTLL3 TBC1D3L STK32A FER1L4 DEGS2	9.02e-05	158	127	5	dc559503bab3ec1b9ea54ef2e896d1be33e5344c
ToppCell	facs-Brain_Myeloid-Cerebellum-24m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PDCD1 ANGPT1 B3GNT8 RASGRP2	9.02e-05	158	127	5	d689feb7f612aef170da76fcf14abf2dd589082b
ToppCell	facs-Brain_Myeloid-Cerebellum-24m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PDCD1 ANGPT1 B3GNT8 RASGRP2	9.02e-05	158	127	5	829ff3df46f173f2ff1c435e9bce35425e603b42
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TBC1D3L ITGA8 PTPRB CADPS ADGRF5	9.58e-05	160	127	5	830e3ef8c9708d25872c3052a0b2682fa9372111
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SLC25A24 STK32B OOEP CHRNA2 RASGRP2	9.58e-05	160	127	5	0bfdaf979e6f128cba2928ce16bca4d3deff8ac9
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	OOEP HPSE STK32A OXTR RASGRP2	9.86e-05	161	127	5	bf70be1de418615b5442ec684552551edaf1f072
ToppCell	facs-Heart-LA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA CACNA1S GCM2 NOXRED1 GRK2	1.17e-04	167	127	5	8ce8d93c79ac6a3f52252b4cec53378c362bfe0a
ToppCell	facs-Heart-LA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA CACNA1S GCM2 NOXRED1 GRK2	1.17e-04	167	127	5	8340f7075d00dccb304cfd4c9b5711ca6dbf7cce
ToppCell	mild_COVID-19_(asymptomatic)-Plasmablast\|World / disease group, cell group and cell class (v2)	NAPSA OOEP MYH14 CADPS FTSJ3	1.17e-04	167	127	5	f26ae4de4804a3486502e3df37eabf3dfca688f5
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DPP10 STK32B LBR CNTN3 LEPROT	1.24e-04	169	127	5	8f397cf4f9fd7c6fa88d01a95289ce2a6bc6938d
ToppCell	droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA GCM2 HPSE B3GNT8 TRAF4	1.34e-04	172	127	5	24ecfda5e43e28f190089770cd2eae5bf2ed292b
ToppCell	droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cells\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA GCM2 HPSE B3GNT8 TRAF4	1.34e-04	172	127	5	db5a31cafce4346fe459d7f35210823fd7004439
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DPP10 DNAH14 GHR CNTN3 CADPS2	1.42e-04	174	127	5	2947e5906b172d149412fa4e77476fce4ea695d2
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1B GCM2 STK32B OOEP SBK2	1.46e-04	175	127	5	f1394aacc8a94ca555dd19aaed5a18da99c6bf40
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1B GCM2 STK32B OOEP SBK2	1.46e-04	175	127	5	7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WWP2 STK32B MGAT4A OOEP CNTN1	1.50e-04	176	127	5	77c3da2eaa072a6baefb5087fd07ec18c5e271cd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA8 OLFML2A PTPRB RIN2 ADGRF5	1.50e-04	176	127	5	64e426f5e84884ce2c29acf6f4b958962a63927f
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1B TTLL3 ITGA8 STK32A SBK2	1.54e-04	177	127	5	8abdf1d970b2f15e17e185f3e612dd5065c88757
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OOEP STK32A GRK3 CADPS ADGRF5	1.58e-04	178	127	5	30ca37f70d267cc9b40ca3e211f16d30360c3e6b
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	NAPSA CYP4B1 STK32A MYH14 ADGRF5	1.62e-04	179	127	5	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAPSA OLFML2B STK32A MYH14 CADPS2	1.62e-04	179	127	5	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DPP10 PKD2L1 GHR CNTN3 CADPS2	1.62e-04	179	127	5	53e700494d251ec5649b2dea5fc7d5aeeeed572b
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA CACNA1S CYP4B1 PTPRB ADGRF5	1.66e-04	180	127	5	243622eee35d38748e945677ff115616e763e3b4
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA CACNA1S CYP4B1 PTPRB ADGRF5	1.66e-04	180	127	5	3a8d9a71efe113d1df3933902a625c0a56812074
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ITGA8 HPSE CHRNA2 RIN2 DSEL	1.70e-04	181	127	5	35bcdcd2651149692e5b150e887c0f450c81d2d4
ToppCell	droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STK32B PTPRB ADGRF5 DEGS2 CADPS2	1.70e-04	181	127	5	2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP4B1 ITGA8 PTPRB ADGRF5 CADPS2	1.70e-04	181	127	5	fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCell	10x5'-bone_marrow-Myeloid_Mac-Macrophage\|bone_marrow / Manually curated celltypes from each tissue	OLFML2B PKD2L1 RIN2 LEPROT TAF1	1.70e-04	181	127	5	d2aa5b53162fb5c4cbbedbd2cb4b2b614e8c4afa
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ITGA8 HPSE CHRNA2 RIN2 DSEL	1.70e-04	181	127	5	154d5e586cab25155c6d06dfe6ae01203b88e0fb
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANGPT1 ITGA8 CHRNA2 RIN2 DSEL	1.75e-04	182	127	5	3d7a8d2ee2137b098248597058974ef5ae09c19e
ToppCell	COVID-19-Epithelial_cells-ECM-high_epithelial\|COVID-19 / group, cell type (main and fine annotations)	NAPSA CYP4B1 STK32A MYH14 ADGRF5	1.79e-04	183	127	5	dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCell	COVID-19-lung-Epithelial\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KCTD7 NAPSA CYP4B1 EEF1G LEPROT	1.79e-04	183	127	5	3a5d00006a195b5a5c27e7ace615e5de73145e97
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	NAPSA CYP4B1 DNAH14 STK32A MYH14	1.79e-04	183	127	5	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ITGA8 HPSE CHRNA2 RIN2 DSEL	1.89e-04	185	127	5	caf4f57f2db9ff72a652c8573e16e7ab180ffc05
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	DPP10 STK32A MYH14 ADGRF5 CADPS2	1.89e-04	185	127	5	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	(2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)\|(2)_5-FU / Stress and Cell class	ANGPT1 OLFML2B PDIA4 GHR RMND1	1.98e-04	187	127	5	6bbf0f7fe203274dae8d582652f35cd3187c0065
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANGPT1 HPSE CHRNA2 RIN2 DSEL	2.03e-04	188	127	5	c66fccdfe68760b8c3efca77e3c25966dc9a8a5f
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	NAPSA CYP4B1 STK32A MYH14 ADGRF5	2.03e-04	188	127	5	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	OLFML2B ITGA8 GHR OLFML2A FAT1	2.03e-04	188	127	5	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	OXR1 ITGA8 PPEF1 PTPRB CADPS2	2.08e-04	189	127	5	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	IPF-Epithelial-Club\|IPF / Disease state, Lineage and Cell class	NAPSA CYP4B1 MYH14 ADGRF5 CADPS2	2.08e-04	189	127	5	f3fcef008ef252b29ac6d567fef27f9acf9cd70f
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	FAT1 PTPRB RIN2 ADGRF5 CADPS2	2.14e-04	190	127	5	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 ANGPT1 ITGA8 GHR CNTN1	2.14e-04	190	127	5	2306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 ANGPT1 ITGA8 GHR CNTN1	2.14e-04	190	127	5	1f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 ANGPT1 ITGA8 GHR CNTN1	2.19e-04	191	127	5	a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	NAPSA DNAH14 STK32A MYH14 ADGRF5	2.19e-04	191	127	5	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	CYP4B1 DNAH14 MYH14 ADGRF5 CADPS2	2.19e-04	191	127	5	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	OLFML2B ITGA8 GHR FAT1 CNTN1	2.19e-04	191	127	5	98b907f8fa024cf32e462323b782c5a371327bbd
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NAPSA DNAH14 MYH14 ADGRF5 CADPS2	2.19e-04	191	127	5	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 ANGPT1 ITGA8 GHR CNTN1	2.24e-04	192	127	5	9093a9e94a25682d109a7f6edc256a25a61103a0
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	NAPSA DNAH14 MYH14 ADGRF5 CADPS2	2.24e-04	192	127	5	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 ANGPT1 ITGA8 GHR CNTN1	2.24e-04	192	127	5	9ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	NAPSA DNAH14 MYH14 ADGRF5 CADPS2	2.24e-04	192	127	5	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	OXR1 PTPRB RIN2 ADGRF5 CADPS2	2.30e-04	193	127	5	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	OXR1 PTPRB RIN2 ADGRF5 CADPS2	2.30e-04	193	127	5	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	ANGPT1 ITGA8 GHR OLFML2A CNTN3	2.30e-04	193	127	5	acad568621ed677031797b8c2e34dafea798d681
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ANGPT1 OLFML2B FAT1 CADPS ADGRF5	2.30e-04	193	127	5	ba6eb29478d16589172f48f9992e5116328c81d6
ToppCell	RV-09._Endothelium_I\|World / Chamber and Cluster_Paper	FRYL PTPRB RIN2 ADGRF5 CADPS2	2.30e-04	193	127	5	e3fa47e2c7cd8a5b69186711c57751f2296de8ae
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANGPT1 ITGA8 OLFML2A CNTN3 CNTN1	2.35e-04	194	127	5	011e14d9ed1393275f892060e7708ffadcd0767f
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	1.53e-05	2	116	2	180849
Disease	Rubinstein-Taybi syndrome due to CREBBP mutations	CREBBP EP300	1.53e-05	2	116	2	cv:C4551859
Disease	Infantile liver failure	MARS1 LARS1	1.53e-05	2	116	2	cv:C5681094
Disease	Menke-Hennekam syndrome	CREBBP EP300	1.53e-05	2	116	2	cv:C5681632
Disease	Rubinstein-Taybi syndrome (implicated_via_orthology)	CREBBP EP300	1.53e-05	2	116	2	DOID:1933 (implicated_via_orthology)
Disease	Rubinstein-Taybi syndrome	CREBBP EP300	1.53e-05	2	116	2	cv:C0035934
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	1.53e-05	2	116	2	C4551859
Disease	Rubinstein-Taybi syndrome (is_implicated_in)	CREBBP EP300	1.53e-05	2	116	2	DOID:1933 (is_implicated_in)
Disease	Rubinstein-Taybi Syndrome	CREBBP EP300	1.53e-05	2	116	2	C0035934
Disease	Squamous cell carcinoma of esophagus	CREBBP FAT1 KMT2D GLO1 EP300	3.76e-05	95	116	5	C0279626
Disease	Neuronal Ceroid-Lipofuscinoses	KCTD7 CLN3	2.27e-04	6	116	2	C0027877
Disease	Bladder Neoplasm	CYP4B1 CREBBP BAP1 KMT2D EP300	2.35e-04	140	116	5	C0005695
Disease	Malignant neoplasm of urinary bladder	CYP4B1 CREBBP BAP1 KMT2D EP300	2.43e-04	141	116	5	C0005684
Disease	glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) measurement	GBA2 SGPL1	3.18e-04	7	116	2	EFO_0800520
Disease	systemic lupus erythematosus (implicated_via_orthology)	PDCD1 LBR EP300	6.51e-04	43	116	3	DOID:9074 (implicated_via_orthology)
Disease	Small cell carcinoma of lung	CREBBP TAF1L EP300	1.27e-03	54	116	3	C0149925
Disease	Metastatic melanoma	STK32B STK32A TAF1	1.27e-03	54	116	3	C0278883
Disease	Diffuse Large B-Cell Lymphoma	CREBBP KMT2D EP300	1.34e-03	55	116	3	C0079744
Disease	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K	FKRP RXYLT1	1.35e-03	14	116	2	C1836373
Disease	alpha-Dystroglycanopathies	FKRP RXYLT1	1.35e-03	14	116	2	C2936406
Disease	Fukuyama Type Congenital Muscular Dystrophy	FKRP RXYLT1	1.35e-03	14	116	2	C0410174
Disease	thalamus volume change measurement	OOEP FAT1	1.35e-03	14	116	2	EFO_0021496
Disease	Muscle eye brain disease	FKRP RXYLT1	1.35e-03	14	116	2	C0457133
Disease	Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1	FKRP RXYLT1	1.35e-03	14	116	2	C4284790
Disease	Walker-Warburg congenital muscular dystrophy	FKRP RXYLT1	1.56e-03	15	116	2	C0265221
Disease	Lymphoma, Follicular, Grade 2	CREBBP KMT2D	1.56e-03	15	116	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	CREBBP KMT2D	1.56e-03	15	116	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	CREBBP KMT2D	1.56e-03	15	116	2	C1956130
Disease	myelodysplastic syndrome (implicated_via_orthology)	CREBBP BAP1	1.56e-03	15	116	2	DOID:0050908 (implicated_via_orthology)
Disease	Lymphoma, Large-Cell, Follicular	CREBBP KMT2D	1.56e-03	15	116	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	CREBBP KMT2D	1.56e-03	15	116	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	CREBBP KMT2D	1.56e-03	15	116	2	C0079758
Disease	Seizures	CACNA1B OXR1 FKRP PIGU CLPB	1.74e-03	218	116	5	C0036572
Disease	T-Cell Lymphoma	KMT2D EP300	1.77e-03	16	116	2	C0079772
Disease	Global developmental delay	CACNA1B OXR1 PIGU TAF1	1.91e-03	133	116	4	C0557874
Disease	macrophage inflammatory protein 1b measurement	TBC1D3 ANGPT1 TBC1D3B TBC1D3F	2.07e-03	136	116	4	EFO_0008219
Disease	breast carcinoma (is_marker_for)	SRD5A1 KMT2D EP300	2.26e-03	66	116	3	DOID:3459 (is_marker_for)
Disease	toxic shock syndrome (is_marker_for)	PDCD1 GRK2	2.51e-03	19	116	2	DOID:14115 (is_marker_for)
Disease	skin pigmentation	TTLL3 CADPS2 USP48	2.57e-03	69	116	3	EFO_0003784
Disease	CCL4 measurement	TBC1D3 TBC1D3F	2.78e-03	20	116	2	EFO_0004751
Disease	Lymphoma, Follicular	CREBBP KMT2D	2.78e-03	20	116	2	C0024301
Disease	bipolar disorder, body mass index	RPGRIP1L CLN3 RIN2	2.90e-03	72	116	3	EFO_0004340, MONDO_0004985
Disease	melanoma	PDCD1 HPSE BAP1 GLO1 EP300	3.03e-03	248	116	5	C0025202
Disease	Prostatic Neoplasms	SRD5A1 CREBBP BAP1 GHR KMT2D MYH14 ALOXE3 TAF1L	3.05e-03	616	116	8	C0033578
Disease	Malignant neoplasm of prostate	SRD5A1 CREBBP BAP1 GHR KMT2D MYH14 ALOXE3 TAF1L	3.05e-03	616	116	8	C0376358
Disease	gestational age, birth measurement	OXR1 OLFML2B	3.06e-03	21	116	2	EFO_0005112, EFO_0006921
Disease	cardiovascular system disease (is_implicated_in)	UBR1 GYS1	3.06e-03	21	116	2	DOID:1287 (is_implicated_in)
Disease	Hereditary Paraganglioma-Pheochromocytoma Syndrome	BAP1 KMT2D	3.67e-03	23	116	2	C1708353
Disease	Autistic Disorder	GHR OXTR GLO1 CNTN3 CADPS2	3.77e-03	261	116	5	C0004352

Protein segments in the cluster

Peptide	Gene	Start	Entry
LYTVLGPWFFGEIID	TMEM62	491	Q0P6H9
LPYFEGDFWPNVLEE	EP300	1501	Q09472
FYLFPNRLEWRGEGE	GRK3	581	P35626
KPFNELWDYEVVEAF	C4orf33	51	Q8N1A6
RYWLFSDEVPGLFIE	BAZ1B	911	Q9UIG0
ELPYFEGDFWPNVLE	CREBBP	1536	Q92793
WIPDIVLYNNADGEF	CHRNA2	141	Q15822
GPVYGFIFLFKWIEE	BAP1	41	Q92560
PSGEYWLGNEFIFAI	ANGPT1	351	Q15389
EFERILQFYWVTGFP	CC2D2B	1366	Q6DHV5
PGAYFRDLWNILDFI	CACNA1B	1211	Q00975
IIFNGIADWLYEEEL	DPP10	221	Q8N608
FYLFPNRLEWRGEGE	GRK2	581	P25098
QVYLPWDEAVDSAFF	ATP8B2	326	P98198
LAFGDLVWVPFIYSF	LBR	456	Q14739
DYIWDFVLYPNGALE	AOC2	466	O75106
FHVGDEWLEFFYPQL	POGLUT1	291	Q8NBL1
LGWFSPGQVFVLDEY	CADPS	701	Q9ULU8
RFANLTPEEFVGDYW	FAT1	3646	Q14517
DFFWAITPIAGDYIL	MGAT4A	416	Q9UM21
ALEDYGVYWPLFVLI	LEPROT	26	O15243
PAGDWEQYRILLFND	PTPRB	401	P23467
EFLLIAFTEYPEWAL	OR9Q1	11	Q8NGQ5
SFGPWEAVADVYDLL	KCTD7	231	Q96MP8
GDIPNFGTVEYWFRL	RPGRIP1L	721	Q68CZ1
YWISAFPAEFDLNPE	RASGRP2	81	Q7LDG7
ELLYRTDFFPGLGWL	MGAT1	256	P26572
WQLLEQYPAAFEFSE	MTMR10	471	Q9NXD2
GNIFLADYWILAEAP	ALOXE3	321	Q9BYJ1
EFNHFEDWLNVFPLY	FER1L4	1181	A9Z1Z3
EEYQREGIPWTFLDF	MYH14	516	Q7Z406
VPVFSVDYGELDFQW	PDCD1	216	Q15116
LAFIQDPDGYWIEIL	GLO1	161	Q04760
LWQLGVDYFDYCPEL	NUP85	416	Q9BW27
FDWFFGYDEVQGLLL	CSKMT	51	A8MUP2
DFPDWREDVLSGFVY	FRYL	606	O94915
EWLEYLLEFAQDAAP	DNAJC16	666	Q9Y2G8
IDEVWPSLFLGDAYA	DUSP13	46	Q9UII6
QLLWDITFRFYGPDL	OXTR	96	P30559
DLTPNIGLFWYFFAE	PIGU	266	Q9H490
ENFDPLPDYWLSLLF	HPSE	396	Q9Y251
EVGWPFSARDEFLLY	ITGA8	841	P53708
LEDLGPQFEFLVAYW	IL20RB	156	Q6UXL0
YNFRVFAWIPEDGFL	DCHS2	1156	Q6V1P9
VFYLEAWLADELFGP	OOEP	51	A6NGQ2
FFIQWSPEIYAEDTG	OXR1	606	Q8N573
DFREWFEFSPYEVGL	PLA2G4E	526	Q3MJ16
APELQDDFYLNLVDW	FZR1	181	Q9UM11
PYEQSEILGYAELWF	DYRK4	51	Q9NR20
IWYPLNLLERVGFEE	EIF2B3	36	Q9NR50
NFEWFLYRPEAPDTA	IGSF8	61	Q969P0
IEVFDPDANTWRLYG	KLHL20	571	Q9Y2M5
GWNIPYEFNESDLRI	DNAH3	3691	Q8TD57
FNELYFLADGGTVWL	GBA2	481	Q9HCG7
EDFYFPWLLIIIFGI	GHR	261	P10912
GYFGDPWNVFDFLIV	CACNA1S	1176	Q13698
DDLSYRWLLNEFPVF	CNTN1	166	Q12860
VLWDFVFEDSLGPYA	DEGS2	296	Q6QHC5
LGWFSPGQVFVLDEY	CADPS2	666	Q86UW7
FLPEEEWNIFLYSGI	DNAH14	2841	Q0VDD8
SLGDGIFWIQERFYE	MBLAC2	11	Q68D91
AVVGVEAWYEPFLFN	SELENOI	201	Q9C0D9
NGWYDEEHPLVFLFL	CLPB	366	Q9H078
APDVYDFFLQWIGRG	CYP4B1	111	P13584
ELAFPLSPDWQVDYE	EEF1G	381	P26641
IIPWDYDVDLGIYLE	FKRP	356	Q9H9S5
VPWYDREANDAVLFG	GYS1	141	P13807
YSDLLLWDFLDVPFN	B3GNT8	206	Q7Z7M8
PLAEADPFYEDFLIW	SBK2	266	P0C263
FIIYDSPWINDVDVF	RXYLT1	226	Q9Y2B1
EKDCPGVLWIFLDYF	SLFN13	691	Q68D06
WFYGPESQLVFLDKF	DSEL	336	Q8IZU8
DPLLDIIFTWYFNGA	CNTN3	526	Q9P232
AAGFLIVDVPFYEWL	TBRG4	591	Q969Z0
IDFAVDESGLWVIYP	OLFML2A	521	Q68BL7
EFYAWLPIGTIVDNE	PPEF1	266	O14829
LVPGEEWEFEVTAFY	IRF3	196	Q14653
QFEYGVPEEDRIWLY	NOXRED1	11	Q6NXP6
WVEKYFGPDFLEQIV	NT5M	146	Q9NPB1
ETYLQLQEAFGWEPF	TCAF1	831	Q9Y4C2
ETYLQLQEAFGWEPF	TCAF2	831	A6NFQ2
DQLKQEFEFWYPVDL	LARS1	656	Q9P2J5
IFPIDNEDLVYGRWE	TAF1L	486	Q8IZX4
SIFPIDNEDLVYGRW	TAF1	466	P21675
ELALFDQFREWPDGY	GCM2	31	O75603
RYTFNEDEGELPEWF	FTSJ3	691	Q8IY81
ITPDFYWDRENLEGL	RMND1	371	Q9NWS8
VNDADIILVEFYAPW	PDIA4	191	P13667
PFLVNLWYSFQDEED	STK32A	81	Q8WU08
LFLLYLPEEDAFWAL	TBC1D3L	196	B9A6J9
YIEAREGWPLIDYVF	MROH2B	386	Q7Z745
EGWPLIDYVFSQFAT	MROH2B	391	Q7Z745
DFAVDENGLWLIYPA	OLFML2B	621	Q68BL8
LLIVWGYEFVFQPES	SGPL1	51	O95470
VFPYFDLWGNVVIDK	ADGRF5	871	Q8IZF2
ADVWFGFLPSIYLVF	CLN3	361	Q13286
YEFVGLEFLPHLQTW	CHST4	291	Q8NCG5
LFLLYLPEEDAFWAL	TBC1D3B	196	A6NDS4
LFLLYLPEEDAFWAL	TBC1D3H	196	P0C7X1
PEEYSLFLFVDETWQ	RIN2	831	Q8WYP3
DGFNEVAPLEWLRYF	WWP2	726	O00308
LFLLYLPEEDAFWAL	TBC1D3F	196	A6NER0
AVYFSEEEWQLLGPL	ZNF75CP	211	Q92670
SDELQFGYEVWREFP	EXT2	546	Q93063
LVGAVLAFPSLYWDD	UBR1	1406	Q8IWV7
LAFPSLYWDDPVDLQ	UBR1	1411	Q8IWV7
LFLLYLPEEDAFWAL	TBC1D3E	196	A0A087X179
YIRVLPGAFDNLLEW	TRAF4	366	Q9BUZ4
DFVFGEDFQPWLIEI	TTLL3	456	Q9Y4R7
EDILGVQAARPWEFY	PIGZ	71	Q86VD9
DFWDFAQGPLLDSLY	PKD2L1	156	Q9P0L9
YADDWVTDPRFLIGF	SRD5A1	141	P18405
EDLYEGFDAFWPSLE	SLC9C2	976	Q5TAH2
PFLVNLWYSFQDEED	STK32B	81	Q9NY57
LFLLYLPEEDAFWAL	TBC1D3D	196	A0A087WVF3
KPEIFVDGWNIYFFD	TUT7	1201	Q5VYS8
LEVFFEGWLKEIYPE	TRIM66	1136	O15016
LFLLYLPEEDAFWAL	TBC1D3G	196	Q6DHY5
LFLLYLPEEDAFWAL	TBC1D3	196	Q8IZP1
AGAEPYEFVSLEWLQ	USP48	481	Q86UV5
EQFPLFEAFLLAAWE	ZFYVE26	1361	Q68DK2
PLEGFEDKVFYVWFD	MARS1	506	P56192
EWRDYFLFNPVTDIE	SLC25A24	146	Q6NUK1
LFLLYLPEEDAFWAL	TBC1D3K	196	A0A087X1G2
FLLYLPEEDAFWALV	USP6	196	P35125
GPEFYFENISLSWEE	TEX13B	31	Q9BXU2
LFLLYLPEEDAFWAL	TBC1D3I	196	A0A087WXS9
LFLLYLPEEDAFWAL	TBC1D3C	196	Q6IPX1
EPQYFRFEGVWLTET	KMT2D	1581	O14686
IFGEALWEPSLVFAF	NAPSA	166	O96009